THEMISMED.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Drug Manufacturers - Specialty & Generic

DCF fair valuemodel estimate

Intrinsic value

$74.47

Price

$119.88

Implied downside

-38%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
THEMISMED.BOThemis Medicare Limited	$120.40	-1.39%	$11.1B	—
HESTERBIO.BOHester Biosciences Limited	$2184.70	+0.78%	$18.6B	—
HESTERBIO.NSHester Biosciences Limited	$2207.70	+1.65%	$18.8B	—
KMCSHIL.BOKMC Speciality Hospitals (India) Limited	$148.30	+11.46%	$24.2B	—
LINCOLN.NSLincoln Pharmaceuticals Limited	$590.70	-1.97%	$11.8B	—
MAXIND.NSMax India Limited	$139.64	+0.37%	$7.3B	—
SIGACHI.BOSigachi Industries Limited	$31.46	-0.22%	$12.0B	—

Source: Financial Modeling Prep · peers by sector/industry

Themis Medicare Limited

Themis Medicare Limited, an Indian pharmaceutical company along with its subsidiaries, manufactures and globally distributes a wide array of medicinal products. Its offerings include both active pharmaceutical ingredients (APIs) and finished drug formulations, addressing various therapeutic areas. These encompass treatments for tuberculosis and malaria, cardiovascular ailments, pain management, infectious diseases, blood disorders (haematinics), nutritional supplements, anesthetics, gynecological conditions, orthopedic issues, and non-steroidal anti-inflammatory drugs. Founded in 1952, the company was initially named Themis Chemicals before adopting its current name, Themis Medicare Limited, in 2001. Its headquarters are located in Mumbai, India.

www.themismedicare.com

Employees: 1,509
IPO / List date: Jul 26, 2001
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds THEMISMED.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in THEMISMED.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded THEMISMED.BO yet.